Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution study

Waldenström, 1944, Incipient myelomatosis or “essential” hyperglobulinemia with fibrinogenopenia—A new syndrome?, Acta Med Scand, 117, 216, 10.1111/j.0954-6820.1944.tb03955.x

2001

Wagner, 1994, Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma, Blood, 12, 3647, 10.1182/blood.V83.12.3647.3647

Herrinton, 1993, Incidence of Waldenstrom's macroglobulinemia, Blood, 82, 3148, 10.1182/blood.V82.10.3148.3148

Gertz, 2000, Waldenstrom's macroglobulinemia, Oncologist, 5, 63, 10.1634/theoncologist.5-1-63

Facon, 1993, Prognostic factors in Waldenstrom's macroglobulinemia: A report of 167 cases, J Clin Oncol, 11, 1553, 10.1200/JCO.1993.11.8.1553

Gobbi, 1994, Study of prognosis in Waldenstrom's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility, Blood, 83, 2939, 10.1182/blood.V83.10.2939.2939

Dimopoulos, 2000, Waldenstrom's macroglobulinemia: Clinical features, complications, and management, J Clin Oncol., 18, 214, 10.1200/JCO.2000.18.1.214

Dhodapkar, 2001, Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003), Blood, 98, 41, 10.1182/blood.V98.1.41

Owen, 2001, Development of diagnostic criteria and identification of prognostic factors, Am J Clin Pathol, 116, 420, 10.1309/4LCN-JMPG-5U71-UWQB

Morel, 2000, Prognostic factors in Waldenström macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients, Blood, 96, 852

Papamichael, 1999, Immunocytoma: A retrospective analysis from St Bartholomew's Hospital—1972 to 1996, J Clin Oncol, 17, 2847, 10.1200/JCO.1999.17.9.2847

Kaplan, 1958, Non-parametric estimation from incomplete observation, Am Stat Assoc J, 53, 457, 10.2307/2281868

Peto, 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1